Sort   by:  
 Page size 
UnknownThe Alzheimer's disease THErapy with NEuroaid (ATHENE) study protocol: Assessing the safety and efficacy of Neuroaid II (MLC901) in patients with mild-to-moderate Alzheimer's disease stable on cholinesterase inhibitors or memantine-A randomized, double-blind, placebo-controlled trial.
Not available
S-EPMC6352850 | biostudies-literature
UnknownEmerging Stroke Risk Factors: A Focus on Infectious and Environmental Determinants.
Not available
S-EPMC10816862 | biostudies-literature
UnknownAssociation Between Dementia and Optical Coherence Tomography Scan Quality.
Not available
S-EPMC12727133 | biostudies-literature
UnknownAge-Related Eye Diseases in Individuals With Mild Cognitive Impairment and Alzheimer's Disease.
Not available
S-EPMC9329945 | biostudies-literature
UnknownCost-effectiveness of MLC601 in post-stroke functional recovery compared with placebo - the CHIMES & CHIMES-E studies.
Not available
S-EPMC11430337 | biostudies-literature
UnknownThe value of patient selection in demonstrating treatment effect in stroke recovery trials: lessons from the CHIMES study of MLC601 (NeuroAiD).
Not available
S-EPMC5054909 | biostudies-literature
UnknownImmunomodulatory sphingosine-1-phosphates as plasma biomarkers of Alzheimer's disease and vascular cognitive impairment.
Not available
S-EPMC7528375 | biostudies-literature
UnknownGlobal mortality from dementia: Application of a new method and results from the Global Burden of Disease Study 2019.
Not available
S-EPMC8315276 | biostudies-literature
UnknownA multi-regression framework to improve diagnostic ability of optical coherence tomography retinal biomarkers to discriminate mild cognitive impairment and Alzheimer's disease.
Not available
S-EPMC8908577 | biostudies-literature
UnknownRetinal thickness predicts the risk of cognitive decline over five years.
Not available
S-EPMC11664827 | biostudies-literature
Sort   by:  
 Page size